Menu
Back to Archived Journals » Gastrointestinal Cancer: Targets and Therapy
Gastrointestinal Cancer: Targets and Therapy ceased publishing in December 2018. All articles that have been published in Gastrointestinal Cancer: Targets and Therapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Gastrointestinal Cancer: Targets and Therapy
ISSN: 1179-9919
- View all (55)
- Volume 8, 2018 (3)
- Volume 7, 2017 (5)
- Volume 6, 2016 (6)
- Volume 5, 2015 (12)
- Volume 4, 2014 (12)
- Volume 3, 2013 (4)
- Volume 2, 2012 (5)
- Volume 1, 2011 (8)
Journal Articles:
- 55 records -
Evidence for improvements to risk stratification in high-risk gastrointestinal stromal tumor patients
Greco A, Rossi S, Ruffolo C, Pauletti B, Dei Tos AP, Morana G, Massani M
Gastrointestinal Cancer: Targets and Therapy 2018, 8:25-36
Published Date: 3 December 2018
Emerging treatment options for BRAF-mutant colorectal cancer
Ursem C, Atreya CE, Van Loon K
Gastrointestinal Cancer: Targets and Therapy 2018, 8:13-23
Published Date: 22 March 2018
Models of intrahepatic cholangiocarcinoma: novel tools and therapeutic applications
Hill MA, Alexander WB, Hezel AF
Gastrointestinal Cancer: Targets and Therapy 2018, 8:1-11
Published Date: 19 February 2018
Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer
Sato Y, Yamashita H, Yagi K, Aikou S, Nishida M, Takenaka Y, Nomura S, Seto Y
Gastrointestinal Cancer: Targets and Therapy 2017, 7:39-45
Published Date: 1 December 2017
Gastric neuroendocrine tumors: management and challenges
Kwon DH, Nakakura EK, Bergsland EK, Dai SC
Gastrointestinal Cancer: Targets and Therapy 2017, 7:31-37
Published Date: 29 September 2017
Current perspectives on hyperthermic intraperitoneal chemotherapy in gastric cancer
Smith SD, Kirkpatrick D, Thomas P, Loggie BW
Gastrointestinal Cancer: Targets and Therapy 2017, 7:19-30
Published Date: 1 September 2017
Pancreatic cancer pain: impact and management challenges
Jones WB, Hale AL
Gastrointestinal Cancer: Targets and Therapy 2017, 7:13-17
Published Date: 24 May 2017
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence
Tran PN, Sarkissian S, Chao J, Klempner SJ
Gastrointestinal Cancer: Targets and Therapy 2017, 7:1-11
Published Date: 5 May 2017
Optimal management of venous thromboembolism in advanced pancreatic cancer with low-molecular-weight heparin: current evidence
Perl G, Brenner B, Ben-Aharon I
Gastrointestinal Cancer: Targets and Therapy 2016, 6:49-54
Published Date: 31 October 2016
Therapeutic potential of mesenchymal stem cells in gastrointestinal cancers – current evidence
Qin J, Zhao Y, Wang Y, Betzler C, Popp FC, Sen Gupta A, Augsburger D, Camaj P, Nelson PJ, Bruns CJ
Gastrointestinal Cancer: Targets and Therapy 2016, 6:41-47
Published Date: 8 September 2016
Animal models of pancreatic cancer and their application in clinical research
Weidenhofer J, Colvin EK, Bond DR, Scarlett CJ
Gastrointestinal Cancer: Targets and Therapy 2016, 6:31-39
Published Date: 25 August 2016
Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives
Bupathi M, Ahn DH, Bekaii-Saab T
Gastrointestinal Cancer: Targets and Therapy 2016, 6:21-30
Published Date: 30 June 2016
Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: utility and experience from the clinic
Kundranda MN, Dragovich T
Gastrointestinal Cancer: Targets and Therapy 2016, 6:13-20
Published Date: 14 January 2016
Pancreatic cancer vaccine: a unique potential therapy
Cappello P, Principe M, Novelli F
Gastrointestinal Cancer: Targets and Therapy 2016, 6:1-11
Published Date: 21 December 2015
Profile of lanreotide autogel and its potential in the treatment of gastroenteropancreatic neuroendocrine tumors
Rinke A, Müller D
Gastrointestinal Cancer: Targets and Therapy 2015, 5:123-130
Published Date: 2 September 2015
Endoscopic radiofrequency ablation therapy for the prevention of esophageal cancer in Barrett’s esophagus
Ha NH, Hummel R, Watson DI
Gastrointestinal Cancer: Targets and Therapy 2015, 5:111-121
Published Date: 29 July 2015
The association between obesity and gastrointestinal cancer
Donohoe CL, Doyle SL, Reynolds JV
Gastrointestinal Cancer: Targets and Therapy 2015, 5:103-109
Published Date: 24 July 2015
Emerging role of microRNAs in the treatment of hepatocellular carcinoma
Callegari E, Domenicali M, Gramantieri L, Negrini M, Sabbioni S
Gastrointestinal Cancer: Targets and Therapy 2015, 5:89-102
Published Date: 14 May 2015
The potential of targeted antiangiogenesis therapies in the treatment of esophageal cancer
Xu WW, Li B, Cheung AL
Gastrointestinal Cancer: Targets and Therapy 2015, 5:79-88
Published Date: 29 April 2015
Ramucirumab: hitting another target in gastric cancer
Cohen MJ, Wainberg ZA
Gastrointestinal Cancer: Targets and Therapy 2015, 5:73-77
Published Date: 24 February 2015
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ
Gastrointestinal Cancer: Targets and Therapy 2015, 5:61-71
Published Date: 24 February 2015
Prospective prediction of resistance to neoadjuvant therapy in patients with locoregional esophageal adenocarcinoma
Rosen DG, Shan W, Lassen N, Johnson C, Oelschlager K, Bierman-Harrar Y, Kesler KA, Maetzold D, Badve S, Cook RW, Saxena R
Gastrointestinal Cancer: Targets and Therapy 2015, 5:53-59
Published Date: 19 February 2015
New insights from animal models of colon cancer: inflammation control as a new facet on the tumor suppressor APC gem
Zeineldin M, Neufeld KL
Gastrointestinal Cancer: Targets and Therapy 2015, 5:39-52
Published Date: 30 January 2015
EGFR signaling in colorectal cancer: a clinical perspective
Saletti P, Molinari F, De Dosso S, Frattini M
Gastrointestinal Cancer: Targets and Therapy 2015, 5:21-38
Published Date: 19 January 2015
Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancreas ductal adenocarcinoma
Narayanan V, Weekes CD
Gastrointestinal Cancer: Targets and Therapy 2015, 5:11-19
Published Date: 6 January 2015
Targeting cancer stem cells in hepatocellular carcinoma
He AR, Smith DC, Mishra L
Gastrointestinal Cancer: Targets and Therapy 2015, 5:1-10
Published Date: 17 December 2014
Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy
Baird A, Lee J, Podvin S, Kurabi A, Dang X, Coimbra R, Costantini T, Bansal V, Eliceiri BP
Gastrointestinal Cancer: Targets and Therapy 2014, 4:131-142
Published Date: 24 October 2014
Targeting cancer stem cells in gastric cancer
Ishimoto T, Baba H
Gastrointestinal Cancer: Targets and Therapy 2014, 4:123-129
Published Date: 15 October 2014
STAT3 as an emerging molecular target in pancreatic cancer
Sharma NK, Shankar S, Srivastava RK
Gastrointestinal Cancer: Targets and Therapy 2014, 4:115-122
Published Date: 25 August 2014
Association between time to disease progression end points and overall survival in patients with neuroendocrine tumors
Singh S, Wang X, Law CHL
Gastrointestinal Cancer: Targets and Therapy 2014, 4:103-113
Published Date: 16 August 2014
Emerging treatments for advanced pancreatic cancer: clinical potential of albumin-bound paclitaxel
Fontana E, Sclafani F, Cunningham D
Gastrointestinal Cancer: Targets and Therapy 2014, 4:89-101
Published Date: 25 June 2014
Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer
Azevedo-Pouly ACP, Schmittgen TD
Gastrointestinal Cancer: Targets and Therapy 2014, 4:75-87
Published Date: 18 June 2014
Critical analysis of the potential for the therapeutic targeting of the Sp1 transcription factor in pancreatic cancer
Jutooru I, Chadalapaka G, Safe S
Gastrointestinal Cancer: Targets and Therapy 2014, 4:65-74
Published Date: 17 June 2014
WNT/β-catenin pathway activation in hepatocellular carcinoma: a clinical perspective
Ma L, Wei W, Chua M-S, So S
Gastrointestinal Cancer: Targets and Therapy 2014, 4:49-63
Published Date: 10 April 2014
Critical analysis of the potential for therapeutic targeting of mammalian target of rapamycin (mTOR) in gastric cancer
Inokuchi M, Kato K, Kojima K, Sugihara K
Gastrointestinal Cancer: Targets and Therapy 2014, 4:39-48
Published Date: 8 April 2014
Assessing the role of the EGF receptor in the development and progression of pancreatic cancer
Cook N, Frese KK, Moore M
Gastrointestinal Cancer: Targets and Therapy 2014, 4:23-37
Published Date: 2 April 2014
Targeting HER2 amplifications in gastric cancer
Ung L, Chua TC, Merrett ND
Gastrointestinal Cancer: Targets and Therapy 2014, 4:11-22
Published Date: 31 January 2014
New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team
Boichuk S, Rausch JL, Duensing A
Gastrointestinal Cancer: Targets and Therapy 2014, 4:1-10
Published Date: 12 December 2013
Warty gastric cancer with polypoid metastases to the gallbladder and urinary bladder
Matsuyama M, Kato K, Goto S, Moritani S, Sentani K, Kuroda M
Gastrointestinal Cancer: Targets and Therapy 2013, 3:35-37
Published Date: 9 September 2013
Adjuvant therapy of pancreatic carcinoma: the experience of Policlinico Umberto I, Università "Sapienza" Rome
De Felice F, Musio D, Cassese R, Masi D, Tombolini V
Gastrointestinal Cancer: Targets and Therapy 2013, 3:29-33
Published Date: 12 August 2013
Anal cancer: current and future treatment strategies
Chin JY, Hong TS, Wo JY
Gastrointestinal Cancer: Targets and Therapy 2013, 3:19-27
Published Date: 17 January 2013
Neoplastic lesions of endocrine cells in the gastrointestinal tract: ten evolving principles as a basis for clinical understanding
Lawrence B, Anderson M, Schimmack S, Findlay M, Kidd M, Modlin I
Gastrointestinal Cancer: Targets and Therapy 2013, 3:1-17
Published Date: 28 December 2012
Treatment of squamous cell and adenocarcinoma of the esophagus
Rathbone B, Jankowski J, Rathbone M
Gastrointestinal Cancer: Targets and Therapy 2012, 2:39-49
Published Date: 13 November 2012
Critical appraisal of the role of everolimus in advanced neuroendocrine tumors of pancreatic origin
Mulet-Margalef N, Capdevila J
Gastrointestinal Cancer: Targets and Therapy 2012, 2:29-37
Published Date: 27 September 2012
Precursors to invasive pancreatic cancer
Smith JA, Singhi AD, Maitra A
Gastrointestinal Cancer: Targets and Therapy 2012, 2:19-27
Published Date: 27 August 2012
Application of miRNA expression analysis on exfoliated colonocytes for diagnosis of colorectal cancer
Murata S, Koga Y, Moriya Y, Akasu T, Fujita S, Yamamoto S, Kakugawa Y, Ohtake Y, Saito N, Matsumura Y
Gastrointestinal Cancer: Targets and Therapy 2012, 2:11-18
Published Date: 4 May 2012
A new method of endoscopic ultrasonography for determining lesion depth in early gastric cancer
Mitsunaga A, Tagata T, Hamano T, Teramoto H, Shirato I, Shirato M, Nishino T
Gastrointestinal Cancer: Targets and Therapy 2012, 2:1-10
Published Date: 29 December 2011
The role of S-1 in the treatment of gastric cancer
Blum MA, Suzuki A, Taketa T, Ajani J
Gastrointestinal Cancer: Targets and Therapy 2011, 1:59-67
Published Date: 16 December 2011
Role of sunitinib for the management of pancreatic neuroendocrine tumors
Reidy-Lagunes DL, Wyluda EEW
Gastrointestinal Cancer: Targets and Therapy 2011, 1:53-57
Published Date: 15 August 2011
Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease
Bystricky B, Okines AFC, Cunningham D
Gastrointestinal Cancer: Targets and Therapy 2011, 1:41-52
Published Date: 18 July 2011